Engineers Gate Manager LP Sells 1,312,406 Shares of Sabra Healthcare REIT, Inc. $SBRA

Engineers Gate Manager LP lessened its holdings in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 55.5% during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,051,928 shares of the real estate investment trust’s stock after selling 1,312,406 shares during the quarter. Engineers Gate Manager LP’s holdings in Sabra Healthcare REIT were worth $20,523,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of SBRA. Rothschild Investment LLC lifted its position in shares of Sabra Healthcare REIT by 164.6% during the fourth quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock worth $27,000 after purchasing an additional 889 shares during the last quarter. Smartleaf Asset Management LLC boosted its stake in shares of Sabra Healthcare REIT by 97.7% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock valued at $27,000 after purchasing an additional 714 shares during the period. Versant Capital Management Inc grew its holdings in shares of Sabra Healthcare REIT by 70.0% in the second quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock worth $29,000 after purchasing an additional 603 shares during the last quarter. Danske Bank A S bought a new position in shares of Sabra Healthcare REIT in the third quarter worth about $30,000. Finally, Larson Financial Group LLC increased its stake in Sabra Healthcare REIT by 42.3% in the 3rd quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock worth $35,000 after buying an additional 553 shares during the period. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Insiders Place Their Bets

In other Sabra Healthcare REIT news, CEO Richard K. Matros sold 200,000 shares of the company’s stock in a transaction on Tuesday, September 8th. The stock was sold at an average price of $20.83, for a total transaction of $4,166,000.00. Following the completion of the sale, the chief executive officer owned 1,657,686 shares in the company, valued at $34,529,599.38. This represents a 10.77% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.09% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

SBRA has been the subject of a number of research analyst reports. Weiss Ratings lowered shares of Sabra Healthcare REIT from a “buy (b)” rating to a “hold (c+)” rating in a report on Tuesday, August 4th. Citizens Jmp raised their target price on shares of Sabra Healthcare REIT from $23.00 to $25.00 and gave the stock a “market outperform” rating in a research report on Wednesday, July 22nd. Robert W. Baird lifted their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a research note on Monday, August 31st. Citigroup reiterated a “market outperform” rating on shares of Sabra Healthcare REIT in a report on Wednesday, July 22nd. Finally, Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Sabra Healthcare REIT in a research note on Wednesday, July 22nd. Six analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $22.17.

Sabra Healthcare REIT Trading Down 0.1%

NASDAQ SBRA opened at $20.79 on Thursday. The company has a debt-to-equity ratio of 0.95, a quick ratio of 3.07 and a current ratio of 3.07. The company has a market capitalization of $5.31 billion, a price-to-earnings ratio of 79.96, a price-to-earnings-growth ratio of 1.58 and a beta of 0.65. The company’s 50-day simple moving average is $20.68 and its two-hundred day simple moving average is $20.20. Sabra Healthcare REIT, Inc. has a one year low of $17.17 and a one year high of $22.77.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) earnings per share for the quarter, missing the consensus estimate of $0.17 by ($0.27). Sabra Healthcare REIT had a return on equity of 2.34% and a net margin of 7.61%.The business had revenue of $230.11 million during the quarter, compared to analysts’ expectations of $219.39 million. During the same period in the previous year, the company posted $0.38 EPS. Sabra Healthcare REIT’s revenue for the quarter was up 24.7% on a year-over-year basis. Equities analysts forecast that Sabra Healthcare REIT, Inc. will post 1.52 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, August 31st. Investors of record on Friday, August 14th were paid a $0.30 dividend. The ex-dividend date of this dividend was Friday, August 14th. This represents a $1.20 dividend on an annualized basis and a yield of 5.8%. Sabra Healthcare REIT’s payout ratio is 461.54%.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net?lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long?term, triple?net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post?acute rehabilitation and research and development laboratories.